Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

16.50
0.0000
Post-market: 16.560.0635+0.38%17:04 EDT
Volume:2.19M
Turnover:36.55M
Market Cap:1.15B
PE:-17.79
High:17.35
Open:16.66
Low:16.27
Close:16.50
52wk High:29.65
52wk Low:12.26
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.90
T/O Rate:3.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:8.80
PE(LYR):-5.42

Loading ...

Tandem Diabetes Care wins CE mark for Control-IQ+ use in adults with type 2 diabetes

Reuters
·
Jun 05

Tandem Diabetes Care Automated Insulin Delivery Systems Receive Ce Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy

THOMSON REUTERS
·
Jun 05

Wells Fargo Upgrades Tandem Diabetes Care to Overweight From Equalweight, Adjusts Price Target to $27 From $21

MT Newswires Live
·
Jun 01

Tandem Diabetes Care, Inc. : Wells Fargo Raises to Overweight From Equal Weight

THOMSON REUTERS
·
Jun 01

Wells upgrades Tandem Diabetes on ‘transformational’ pharmacy model

TIPRANKS
·
Jun 01

Tandem Diabetes Care Is Maintained at Neutral by Citigroup

Dow Jones
·
May 29

Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs

TIPRANKS
·
May 27

Tandem Diabetes Care shareholders approve charter amendments at annual meeting

Reuters
·
May 22

Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook

TIPRANKS
·
May 20

Tandem Diabetes Care Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 19

Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged

TIPRANKS
·
May 15

Tandem Diabetes Care Inc - Company Strategy and 2026 Goals Remain Unchanged - SEC Filing

THOMSON REUTERS
·
May 15

Tandem Diabetes Care Inc - Mark Novara, Evp and Chief Commercial Officer, to Be Terminated Without Cause - SEC Filing

THOMSON REUTERS
·
May 15

Tandem Diabetes Care Inc : Benchmark Initiates Coverage With Hold Rating

THOMSON REUTERS
·
May 12

Tandem Diabetes initiated with a Hold at Benchmark

TIPRANKS
·
May 12

Stock Track | Tandem Diabetes Care Plummets 5.23% Intraday on Analyst Price Target Cuts

Stock Track
·
May 11

Tandem Diabetes Care Is Maintained at Overweight by Barclays

Dow Jones
·
May 11

Tandem Diabetes Care (TNDM) Gets a Buy from Barclays

TIPRANKS
·
May 11

Tandem Diabetes Care Charts Growth Amid Transition

TIPRANKS
·
May 09

Truist Cuts Price Target on Tandem Diabetes Care to $31 From $35, Keeps Buy Rating

MT Newswires Live
·
May 08